ResearcherUniversity of CopenhagenActive in the last 2 years
Sidsel C. Lindgaard
Matched on ORCID iD 0000-0002-1455-5440; OpenAlex author ID A5015626454. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2021: 1 paper · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers
Papers 7
- Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analys… Co-author DOI 10.1016/j.jlb.2025.100441↗
- The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. First author DOI 10.1158/1078-0432.ccr-25-0758↗
- Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.esmoop.2024.103489↗
- Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer. Co-author DOI 10.1002/cam4.5240↗
- The PANcreatic Disease ReseArch (PANDoRA) consortium: Ten years' experience of association studies to understand the genetic architecture of pancreatic cancer. Co-author DOI 10.1016/j.critrevonc.2023.104020↗
- Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy. Co-author DOI 10.3390/cancers14133250↗
- Circulating Protein Biomarkers for Use in Pancreatic Ductal Adenocarcinoma Identification. Co-author DOI 10.1158/1078-0432.ccr-20-4215↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Julia Sidenius Johansen · 4 shared papers, 2021–2025 · strength 0.68
- Paper The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. DOI 10.1158/1078-0432.ccr-25-0758↗
- Paper Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer. DOI 10.1002/cam4.5240↗
- Paper Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing… DOI 10.3390/cancers14133250↗
- Inna Markovna Chen · 4 shared papers, 2021–2025 · strength 0.68
- Paper The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. DOI 10.1158/1078-0432.ccr-25-0758↗
- Paper Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer. DOI 10.1002/cam4.5240↗
- Paper Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing… DOI 10.3390/cancers14133250↗
- Dorte Lisbet Nielsen · 4 shared papers, 2021–2024 · strength 0.67
- Paper Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic du… DOI 10.1016/j.esmoop.2024.103489↗
- Paper Prognostic value of circulating proteins in patients undergoing surgery for pancreatic cancer. DOI 10.1002/cam4.5240↗
- Paper Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing… DOI 10.3390/cancers14133250↗
- Karen‐Lise Garm Spindler · 2 shared papers, 2025 · strength 0.48
- Paper Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic can… DOI 10.1016/j.jlb.2025.100441↗
- Paper The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. DOI 10.1158/1078-0432.ccr-25-0758↗
- Morten Bækbo Ladekarl · 2 shared papers, 2025 · strength 0.48
- Paper Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic can… DOI 10.1016/j.jlb.2025.100441↗
- Paper The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. DOI 10.1158/1078-0432.ccr-25-0758↗
- Mette M. Steiniche · 2 shared papers, 2025 · strength 0.48
- Paper Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic can… DOI 10.1016/j.jlb.2025.100441↗
- Paper The Prognostic Impact of Early ctDNA Kinetics in Metastatic Pancreatic Cancer Using the ctDNA-RECIST. DOI 10.1158/1078-0432.ccr-25-0758↗
- Astrid Zedlitz Johansen · 2 shared papers, 2022–2023 · strength 0.33
- Carsten Palnæs Hansen · 2 shared papers, 2021–2023 · strength 0.30
- Lars Henrik Jensen · 1 shared paper, 2025 · strength 0.23
- Louise S. Rasmussen · 1 shared paper, 2025 · strength 0.23
- I.M. Chen · 1 shared paper, 2024 · strength 0.22
- Susann Theile · 1 shared paper, 2024 · strength 0.22
- Troels Dreier Christensen · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.